Funding programs in United States
Hand-checked programs plus official open data. Each links to its official page. Loans and private funders are labelled.
United States grant list United States funders United States student funding guide
Open-data catalog: Nonprofits and charities
- Establishing Pediatric CNS Pharmacodynamic Measures as Tools to Enable Psychiatric Indications in Adolescents · National Institutes of Health · United States (federal) · Forecast
- Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional) · National Institutes of Health · United States (federal) · Closes 18 November 2026
- Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional) · National Institutes of Health · United States (federal) · Closes 18 November 2026
- Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional) · National Institutes of Health · United States (federal) · Closes 16 November 2026
- Expanding the Target Landscape by Drugging the Undruggable (R21 Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Closes 17 February 2028
- Expanding the Therapeutic Pipeline for Treating and Preventing Alzheimer's Disease and Related Dementias: Preclinical Validation and Drug Discovery for Novel Candidate Targets (U01 Clinical Trial Not · National Institutes of Health · United States (federal) · Forecast
- Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional) · National Institutes of Health · United States (federal) · Closes 16 June 2028
- Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases · National Institutes of Health · United States (federal) · Forecast
- Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required) · National Institutes of Health · United States (federal) · Closes 2 November 2026
- Exploratory Grants in Cancer Control (R21 Clinical Trial Optional) · National Institutes of Health · United States (federal) · Closes 7 September 2028
- Exploratory Studies to Investigate Mechanisms of HIV infection, Replication, Latency, and/or Pathogenesis in the Context of Substance Use Disorders (R01 Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Recurring, next intake TBA
- Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Closes 7 January 2028
- Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional) · National Institutes of Health · United States (federal) · Closes 7 January 2028
- Exposomic Contributions to ADRD Pathology and Resilience · National Institutes of Health · United States (federal) · Forecast
- Extracellular Vesicle Therapeutics for Regenerative Medicine (ExTReMe) · National Institutes of Health · United States (federal) · Forecast
- Family Smoking Prevention and Tobacco Control Act Regulatory Research (Assistance Listing 93.678) · Health And Human Services, Department Of / National Institutes Of Health · United States (federal) · Dates vary
- Feasibility Clinical Trials of Mind and Body Interventions for NCCIH High Priority Research Topics (R34 Clinical Trial Required) · National Institutes of Health · United States (federal) · Closes 17 November 2026
- Feasibility Studies to Inform the Design of Future Clinical Trials · National Institutes of Health · United States (federal) · Forecast
- Feasibility Trials of the NIH Music-based Interventions Toolkit for Brain Disorders of Aging (R34 Clinical Trial Required) · National Institutes of Health · United States (federal) · Recurring, next intake TBA
- Firearm Injury and Mortality Prevention Research (Assistance Listing 93.00Q) · Health And Human Services, Department Of / National Institutes Of Health · United States (federal) · Dates vary
- First in Human and Early Stage Clinical Trials of Novel Investigational Drugs or Neuromodulatory Device-based Interventions for Psychiatric Disorders (U01 Clinical Trial Required) · National Institutes of Health · United States (federal) · Closes 15 October 2027
- Focused Technology Research and Development (R01 Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Closes 7 January 2028
- Fogarty International Center - Other Research (Assistance Listing 93.TW2) · Health And Human Services, Department Of / National Institutes Of Health · United States (federal) · Dates vary
- Fogarty International Center - Research Centers (Assistance Listing 93.TW3) · Health And Human Services, Department Of / National Institutes Of Health · United States (federal) · Dates vary
- Fogarty International Center - Research Projects (Assistance Listing 93.TW1) · Health And Human Services, Department Of / National Institutes Of Health · United States (federal) · Dates vary
- Fogarty International Center - Training, Institutional (Assistance Listing 93.TW4) · Health And Human Services, Department Of / National Institutes Of Health · United States (federal) · Dates vary
- Forecast for NIH Blueprint and BRAIN Initiative ACTION Potential Program (F99/K00 Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Forecast
- Forecast for NINDS Exploratory Grant Program in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Research (P20 - Clinical Trial Optional) · National Institutes of Health · United States (federal) · Forecast
- Forecast to Publish a Funding Opportunity Announcement for Cancer Epidemiology Cohorts: Building the Next Generation of Research Cohorts (U01 Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Forecast
- Forecast to Publish a Funding Opportunity Announcement for Copy of Integrative Neuroscience Initiative on Alcoholism (INIA) Consortia Administrative Resource Core (U24) (Clinical Trial Optional) · National Institutes of Health · United States (federal) · Forecast
- Forecast to Publish a Funding Opportunity Announcement for Copy of Integrative Neuroscience Initiative on Alcoholism (INIA) Consortia Research Resource (U24) (Clinical Trial Optional) · National Institutes of Health · United States (federal) · Forecast
- Forecast to Publish a Funding Opportunity Announcement for EmbraceHealth Clinical Research Network to Reduce Health Disparities - Coordinating Center · National Institutes of Health · United States (federal) · Forecast
- Forecast to Publish a Funding Opportunity Announcement for Integrative Neuroscience Initiative on Alcoholism (INIA) Consortia (U01 Clinical Trial Optional) · National Institutes of Health · United States (federal) · Forecast
- Forecast to Publish a Funding Opportunity Announcement for Limited Competition for the Continuation of the National Consortium on Alcohol and Neurodevelopment in Adolescence (NCANDA) Research Project · National Institutes of Health · United States (federal) · Forecast
- Forecast to Publish a Funding Opportunity Announcement for the Consortium on the Neurobiology of Adolescent Drinking in Adulthood (NADIA) Administrative Resource (Collaborative U24 - Clinical Trials n · National Institutes of Health · United States (federal) · Forecast
- Forecast to Publish a Funding Opportunity Announcement for the Consortium on the Neurobiology of Adolescent Drinking in Adulthood (NADIA) Research Resource (Collaborative U24 - Clinical Trials not all · National Institutes of Health · United States (federal) · Forecast
- Forecast to Publish a Notice of Funding Opportunity Announcement for Addressing Determinants of Health Disparities Among Rural Populations (R01 - Clinical Trial Optional) · National Institutes of Health · United States (federal) · Forecast
- Forecast to Publish a Notice of Funding Opportunity for Academic Career Excellence (ACE) Award (K32 - Clinical Trial Required) · National Institutes of Health · United States (federal) · Forecast
- Forecast to Publish a Notice of Funding Opportunity for Paul Calabresi Career Development Award in Clinical Oncology (K12 Clinical Trial Optional) · National Institutes of Health · United States (federal) · Forecast
- Forecast to Publish a Notice of Funding Opportunity for SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies Toward Commercialization (R44 Clinical Trial Optional · National Institutes of Health · United States (federal) · Forecast
- Forecast to Publish a Notice of Funding Opportunity for Small Business Transition Grant For Early Career Scientists (R41/R42 Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Forecast
- Forecast to Renew the Funding Opportunity Announcement for Multiple Chronic Disease Research Centers Coordinating Center (U24 Clinical Trial Not Required) · National Institutes of Health · United States (federal) · Forecast
- Forecast to Renew the Notice of Funding Opportunity Announcement for the Multiple Chronic Disease Research Centers · National Institutes of Health · United States (federal) · Forecast
- Full-Scale Hybrid Effectiveness-Implementation Trials for Mental Health Interventions (R01 - Clinical Trial Required) · National Institutes of Health · United States (federal) · Closes 15 October 2027
- Functional Target Validation for Alzheimer's Disease-Related Dementias · National Institutes of Health · United States (federal) · Forecast
- Functional Validation and/or Characterization of Genes or Variants Implicated in Substance Use Disorders (R21/R33 Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Recurring, next intake TBA
- Funding Opportunity Announcement for Impact of Environmental Exposures on Gut-Brain Signaling in Neurological Conditions (R01) · National Institutes of Health · United States (federal) · Forecast
- Gabriella Miller Kids First Pediatric Research (Assistance Listing 93.1KF) · Health And Human Services, Department Of / National Institutes Of Health · United States (federal) · Dates vary
- Gabriella Miller Kids First Training and Outreach Core (U24 Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Closes 8 January 2027
- Genomic and Biologic Therapies for ADRD (U01 Clinical Trial Optional) · National Institutes of Health · United States (federal) · Forecast
- Genomic Community Resources (U24 Clinical Trials Not Allowed) · National Institutes of Health · United States (federal) · Forecast
- Genomic Data Generation Center for the Gabriella Miller Kids First Pediatric Research Program (U24 Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Closes 8 January 2027
- Genomic Variant Interactions With Other Variants Or The Environment (UM1 Clinical Trials Not Allowed) · National Institutes of Health · United States (federal) · Closes 14 December 2026
- George M. O’Brien Urology Cooperative Research Centers Program (U54 Clinical Trial Optional) · National Institutes of Health · United States (federal) · Forecast
- Glioblastoma Therapeutics Network (GTN) (U19 Clinical Trial Required) · National Institutes of Health · United States (federal) · Closes 11 January 2027
- Global Brain and Nervous System Disorders Research Across the Lifespan - Exploratory Grants · National Institutes of Health · United States (federal) · Forecast
- Global Collaborative Research Training on Non-Communicable Diseases and Disorders Across the Lifespan · National Institutes of Health · United States (federal) · Forecast
- Global Infectious Disease Research Training Program (D43 Clinical Trial Optional) · National Institutes of Health · United States (federal) · Recurring, next intake TBA
- Global Infectious Diseases Research Training Program (D43 Clinical Trial Optional) · National Institutes of Health · United States (federal) · Forecast
- Grand Opportunity in Medications Development for Substance-Use Disorders (U01 Clinical Trial Optional) · National Institutes of Health · United States (federal) · Recurring, next intake TBA
- Grants for Early Medical/Surgical Specialists' Transition to Aging Research (GEMSSTAR) (R03 Clinical Trial Optional) · National Institutes of Health · United States (federal) · Closes 16 July 2028
- HAZMAT Training at DOE Nuclear Weapons Complex (UH4 Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Recurring, next intake TBA
- HEAL Initiative: Integrative Management of chronic Pain and OUD for Whole Recovery (IMPOWR) - Building Engagement, Assistance, Capacity, Outreach, and Networks (BEACON) Center (U2C Clinical Trial Not · National Institutes of Health · United States (federal) · Closes 26 January 2027
- HEAL Initiative: Integrative Management of Chronic Pain and OUD for Whole Recovery (IMPOWR): Research Centers (RM1 Clinical Trial Required) · National Institutes of Health · United States (federal) · Closes 26 January 2027
- HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional) · National Institutes of Health · United States (federal) · Closes 20 February 2029
- HEAL Initiative: Optimization of Therapeutic Medical Devices through Team Science Mechanistic Research (RM1) · National Institutes of Health · United States (federal) · Forecast
- HEAL Initiative: Pain Management Effectiveness Research Network: Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required) · National Institutes of Health · United States (federal) · Forecast
- HEAL Initiative: Program to Reveal and Evaluate Cells-to-gene Information that Specify Intricacies, Origins and the Nature of (PRECISION) Human Pain Network · National Institutes of Health · United States (federal) · Forecast
- HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Closes 15 January 2027
- HEAL Initiative: Translating Addiction Epidemiology, Prevention, Treatment, and Recovery Research into Practice (R61/R33 - Clinical Trial Optional) · National Institutes of Health · United States (federal) · Closes 9 February 2029
- HEAL Initiative: Translating Research to Practice to End the Overdose Crisis (R33 Clinical Trial Optional) · National Institutes of Health · United States (federal) · Recurring, next intake TBA
- HEAL Initiative: Translating Research to Practice to End the Overdose Crisis (R61/R33 Clinical Trial Optional) · National Institutes of Health · United States (federal) · Recurring, next intake TBA
- HEAL Initiative: Understanding Individual Differences in Human Pain Conditions (R01 - Clinical Trial Optional) · National Institutes of Health · United States (federal) · Recurring, next intake TBA
- Health and Extreme Weather Research Coordination and Data Center (U2C - Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Forecast
- Health and Extreme Weather Solutions-Focused Research Hubs (U54 - Clinical Trial Optional) · National Institutes of Health · United States (federal) · Forecast
- High Impact, Interdisciplinary Science in NIDDK Research Areas (RC2 Clinical Trial Optional) · National Institutes of Health · United States (federal) · Recurring, next intake TBA
- High Priority HIV and Substance Use Research (R01 Clinical Trial Optional) · National Institutes of Health · United States (federal) · Closes 6 March 2027
- High Priority HIV and Substance Use Research (RM1 Clinical Trial Optional) · National Institutes of Health · United States (federal) · Closes 5 March 2027
- High-End Instrumentation (HEI) Grant Program (S10 Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Recurring, next intake TBA
- High-Priority Research in Tobacco Regulatory Science (Clinical Trial Optional) · National Institutes of Health · United States (federal) · Forecast
- HIV Prevention and Alcohol (R01 Clinical Trials Optional) · National Institutes of Health · United States (federal) · Recurring, next intake TBA
- HIV Prevention and Alcohol (R61/R33 Clinical Trials Optional) · National Institutes of Health · United States (federal) · Forecast
- HIV/AIDS Clinical Trials Network Clinical Trials Units · National Institutes of Health · United States (federal) · Forecast
- HIV/AIDS Clinical Trials Network Laboratory Centers · National Institutes of Health · United States (federal) · Forecast
- HIV/AIDS Clinical Trials Network Leadership and Operations Centers · National Institutes of Health · United States (federal) · Forecast
- HIV/AIDS Clinical Trials Network Statistical and Data Management Centers · National Institutes of Health · United States (federal) · Forecast
- Hubs of Interdisciplinary Research and Training in Global Environmental and Occupational Health (GEOHealth) · National Institutes of Health · United States (federal) · Forecast
- Human Genome Research - Other Research (Assistance Listing 93.HG3) · Health And Human Services, Department Of / National Institutes Of Health · United States (federal) · Dates vary
- Human Genome Research - Research Centers (Assistance Listing 93.HG2) · Health And Human Services, Department Of / National Institutes Of Health · United States (federal) · Dates vary
- Human Genome Research - Research Projects (Assistance Listing 93.HG1) · Health And Human Services, Department Of / National Institutes Of Health · United States (federal) · Dates vary
- Human Genome Research - Small Business (Assistance Listing 93.HG6) · Health And Human Services, Department Of / National Institutes Of Health · United States (federal) · Dates vary
- Human Genome Research - Training, Individual (Assistance Listing 93.HG5) · Health And Human Services, Department Of / National Institutes Of Health · United States (federal) · Dates vary
- Human Genome Research - Training, Institutional (Assistance Listing 93.HG4) · Health And Human Services, Department Of / National Institutes Of Health · United States (federal) · Dates vary
- Human Genome Research (Assistance Listing 93.172) · Health And Human Services, Department Of / National Institutes Of Health · United States (federal) · Dates vary
- Human Virome Program: Developing novel and innovative tools to interrogate and annotate the human virome (U01 Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Recurring, next intake TBA
- IDeA Networks of Biomedical Research Excellence (INBRE) · National Institutes of Health · United States (federal) · Forecast
- IGVF Data and Coordinating Center (U24 Clinical trials Not Allowed) · National Institutes of Health · United States (federal) · Closes 14 December 2026
- Illuminating AD/ADRD Genome to Enable Precision Genomic Medicine · National Institutes of Health · United States (federal) · Forecast
- Imaging - Science Track Award for Research Transition (I/START) (R03 Clinical Trial Optional) · National Institutes of Health · United States (federal) · Recurring, next intake TBA
- Immune Drivers of Autoimmune Disease · National Institutes of Health · United States (federal) · Forecast
‹ Previous Page 4 of 11 Next ›
Information only. GrantSift is not affiliated with any funder. A match means a program is likely eligible or worth checking, not that you will be funded. Always confirm details on the official page. Applying through official portals is free.